InvestSMART

Cellmid Limited (ASX: CDY) - Announcements

- Current share price for CDY : $0.056

ASX company news and announcements for Cellmid Limited (CDY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cellmid Limited (CDY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cellmid Limited (CDY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cellmid Limited (CDY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Pause in Trading 14 Apr 2020 10:01AM $0.300 $0.056 fallen by 81.33%
- Appendix 2A and Cleansing Notice 14 Apr 2020 8:56AM $0.300 $0.056 fallen by 81.33%
- Proposed issue of Securities - CDY 8 Apr 2020 9:25AM $0.355 $0.056 fallen by 84.23%
- Reinstatement to Official Quotation 7 Apr 2020 10:03AM $0.270 $0.056 fallen by 79.26%
- Proposed issue of Securities - CDY 7 Apr 2020 10:03AM $0.270 $0.056 fallen by 79.26%
- Cellmid Share Placement Raises $6 Million 7 Apr 2020 10:02AM $0.270 $0.056 fallen by 79.26%
- Response to ASX Query Letter 6 Apr 2020 6:15PM $0.270 $0.056 fallen by 79.26%
- Suspension from Official Quotation 6 Apr 2020 12:03PM $0.270 $0.056 fallen by 79.26%
- Trading Halt 2 Apr 2020 9:48AM $0.270 $0.056 fallen by 79.26%
- Reinstatement to Official Quotation 27 Mar 2020 7:01PM $0.099 $0.056 fallen by 43.43%
- Market Update on COVID-19 27 Mar 2020 7:01PM $0.099 $0.056 fallen by 43.43%
- Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement 27 Mar 2020 6:18PM $0.099 $0.056 fallen by 43.43%
- Suspension from Official Quotation 24 Mar 2020 10:24AM $0.099 $0.056 fallen by 43.43%
- Trading Halt 20 Mar 2020 9:59AM $0.099 $0.056 fallen by 43.43%
- Appendix 3G 4 Mar 2020 10:59AM $0.130 $0.056 fallen by 56.92%
- Appendix 4D, Half Year Accounts and Presentation 26 Feb 2020 11:39AM $0.165 $0.056 fallen by 66.06%
- Cellmid's Evolis Patent to be Granted in China 4 Feb 2020 9:51AM $0.200 $0.056 fallen by 72%
- Appendix 4C and Notes to Appendix 4C 30 Jan 2020 10:07AM $0.220 $0.056 fallen by 74.55%
- Key Midkine Antibody Patents Granted in the US and Europe 6 Jan 2020 9:43AM $0.210 $0.056 fallen by 73.33%
- Cellmid Reports on QVC Sales 5 Dec 2019 1:41PM $0.255 $0.056 fallen by 78.04%
- Change in substantial holding 22 Nov 2019 9:16AM $0.240 $0.056 fallen by 76.67%
- Change of Director's Interest Notice - Eck 22 Nov 2019 9:10AM $0.240 $0.056 fallen by 76.67%
- Change of Director's Interest Notice - Halasz 22 Nov 2019 9:08AM $0.240 $0.056 fallen by 76.67%
- Appendix 3B and Cleansing Notice 20 Nov 2019 4:29PM $0.230 $0.056 fallen by 75.65%
- Results of Annual General Meeting 19 Nov 2019 5:22PM $0.230 $0.056 fallen by 75.65%

126 - 150 of 530 results

Page 6 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.